Catalent Total Assets 2012-2020 | CTLT

Catalent total assets from 2012 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Catalent total assets for the quarter ending March 31, 2020 were $7.080B, a 57.57% increase year-over-year.
  • Catalent total assets for 2019 were $6.184B, a 36.48% increase from 2018.
  • Catalent total assets for 2018 were $4.531B, a 31.17% increase from 2017.
  • Catalent total assets for 2017 were $3.454B, a 11.75% increase from 2016.
Catalent Annual Total Assets
(Millions of US $)
2019 $6,184
2018 $4,531
2017 $3,454
2016 $3,091
2015 $3,138
2014 $3,090
2013 $2,950
2012 $3,139
2011 $0
Catalent Quarterly Total Assets
(Millions of US $)
2020-03-31 $7,080
2019-12-31 $6,195
2019-09-30 $6,120
2019-06-30 $6,184
2019-03-31 $4,493
2018-12-31 $4,442
2018-09-30 $4,500
2018-06-30 $4,531
2018-03-31 $4,554
2017-12-31 $4,387
2017-09-30 $3,785
2017-06-30 $3,454
2017-03-31 $3,285
2016-12-31 $3,154
2016-09-30 $3,128
2016-06-30 $3,091
2016-03-31 $3,058
2015-12-31 $3,035
2015-09-30 $3,056
2015-06-30 $3,138
2015-03-31 $2,974
2014-12-31 $3,038
2014-09-30 $2,951
2014-06-30 $3,090
2014-03-31 $3,091
2013-12-31 $3,057
2013-09-30 $0
2013-06-30 $2,950
2013-03-31 $0
2012-06-30 $3,139
2011-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.657B $2.518B
Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the pharmaceutical industry including small molecules, large molecule biologics and consumer health products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. Catalent, Inc. is headquartered in Somerset, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.459B 42.94
Takeda Pharmaceutical (TAK) Japan $57.222B 9.97
Astellas Pharma (ALPMY) Japan $29.044B 14.72
Eisai (ESALY) Japan $25.804B 21.81
UCB SA (UCBJF) Belgium $24.702B 0.00
Merck (MKGAF) Germany $17.189B 22.54
Grifols, S.A (GRFS) Spain $12.541B 15.33
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.735B 41.56
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.852B 49.74
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.531B 0.00
Orion OYJ (ORINY) Finland $7.077B 24.56
Jazz Pharmaceuticals (JAZZ) Ireland $6.992B 11.57
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
United Therapeutics (UTHR) United States $5.009B 11.58
Arrowhead Pharmaceuticals (ARWR) United States $4.115B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
Hypermarcas (HYPMY) Brazil $3.957B 14.56
FibroGen (FGEN) United States $3.938B 0.00
Nektar Therapeutics (NKTR) United States $3.889B 0.00
ChemoCentryx (CCXI) United States $3.417B 0.00
PTC Therapeutics (PTCT) United States $3.238B 0.00
Sage Therapeutics (SAGE) United States $2.632B 0.00
Pacira BioSciences (PCRX) United States $2.458B 65.56
Taro Pharmaceutical Industries (TARO) Israel $2.404B 11.64
Cronos Group (CRON) Canada $1.973B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.849B 0.00
Xencor (XNCR) United States $1.840B 0.00
USANA Health Sciences (USNA) United States $1.735B 16.34
Ironwood Pharmaceuticals (IRWD) United States $1.626B 11.33
Corcept Therapeutics (CORT) United States $1.611B 14.83
Revolution Medicines (RVMD) United States $1.547B 0.00
Indivior (INVVY) United States $1.545B 19.18
Akebia Therapeutics (AKBA) United States $1.430B 0.00
Heron Therapeutics (HRTX) United States $1.391B 0.00
Zogenix (ZGNX) United States $1.343B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.320B 12.60
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.133B 0.00
Karyopharm Therapeutics (KPTI) United States $1.119B 0.00
Esperion Therapeutics (ESPR) United States $1.049B 0.00
VAXART, INC (VXRT) United States $1.003B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.943B 589.50
Tilray (TLRY) Canada $0.931B 0.00
Translate Bio (TBIO) United States $0.927B 0.00
Altimmune (ALT) United States $0.876B 0.00
Endo (ENDP) Ireland $0.779B 1.15
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
ImmunoGen (IMGN) United States $0.708B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.700B 0.00
Trillium Therapeutics (TRIL) Canada $0.699B 0.00
Collegium Pharmaceutical (COLL) United States $0.633B 0.00
Siga Technologies (SIGA) United States $0.622B 64.00
Flexion Therapeutics (FLXN) United States $0.608B 0.00
Aerie Pharmaceuticals (AERI) United States $0.586B 0.00
Radius Health (RDUS) United States $0.557B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Molecular Templates (MTEM) United States $0.527B 0.00
Ardelyx (ARDX) United States $0.514B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
Corbus Pharmaceuticals Holdings (CRBP) United States $0.479B 0.00
DURECT (DRRX) United States $0.467B 0.00
TherapeuticsMD (TXMD) United States $0.454B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.448B 0.00
Ocular Therapeutix (OCUL) United States $0.438B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.436B 0.00
Organogenesis Holdings (ORGO) United States $0.427B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.419B 10.13
Calithera Biosciences (CALA) United States $0.318B 0.00
Harpoon Therapeutics (HARP) United States $0.316B 0.00
IMV INC (IMV) Canada $0.315B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.313B 0.00
Redhill Biopharma (RDHL) Israel $0.309B 0.00
OptiNose (OPTN) United States $0.305B 0.00
Rafael Holdings (RFL) United States $0.299B 0.00
MEI Pharma (MEIP) United States $0.295B 0.00
PROFOUND MEDICL (PROF) Canada $0.294B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.269B 0.00
Lannett Co Inc (LCI) United States $0.251B 5.51
CASI Pharmaceuticals (CASI) United States $0.229B 0.00
Aquestive Therapeutics (AQST) United States $0.211B 0.00
Nature's Sunshine Products (NATR) United States $0.209B 20.65
KalVista Pharmaceuticals (KALV) United States $0.207B 0.00
Nivalis Therapeutics (ALPN) United States $0.197B 0.00
Taiwan Liposome (TLC) Taiwan $0.195B 0.00
Onconova Therapeutics (ONTX) United States $0.192B 0.00
Heat Biologics (HTBX) United States $0.184B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.177B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 7.74
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.137B 0.00
Xeris Pharmaceuticals (XERS) United States $0.126B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.117B 0.00
Addex Therapeutics (ADXN) Switzerland $0.115B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
MediWound (MDWD) Israel $0.106B 0.00
Recro Pharma (REPH) United States $0.104B 0.00
Biomerica (BMRA) United States $0.104B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.103B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.098B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
Hemispherx BioPharma (AIM) United States $0.098B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Lipocine (LPCN) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.087B 0.00
ElectroCore (ECOR) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
PolarityTE (PTE) United States $0.058B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.058B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
IsoRay (ISR) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.044B 8.26
GTx (ONCT) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Vical (BBI) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 34.77
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00